Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-07 Option Award | 2024-05-09 7:07 pm | 2026-05-07 2034-05-07 | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 20,767 | $300.3 | 82,656 (Direct) | View |
| 2024-05-07 Option Award | 2024-05-09 7:07 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 3,196 | $0 | 82,656 (Direct) | View |
| 2024-05-05 Tax Withholding | 2024-05-07 8:37 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 633 | $311.29 | 58,693 (Direct) | View |
| 2024-05-02 Tax Withholding | 2024-05-03 7:24 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 650 | $277.37 | 59,326 (Direct) | View |
| 2024-04-30 Tax Withholding | 2024-05-01 7:54 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 690 | $276.38 | 59,976 (Direct) | View |
| 2024-03-18 Tax Withholding | 2024-03-20 8:11 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 6,202 | $268.87 | 60,666 (Direct) | View |
| 2024-03-06 Option Award | 2024-03-08 5:32 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP & Chief Technology Officer | 12,407 | $0 | 66,653 (Direct) | View |
| 2023-11-28 Gift | 2023-11-29 8:44 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 165 | $0 | 54,164 (Direct) | View |
| 2023-05-05 Tax Withholding | 2023-05-09 7:24 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 594 | $231.89 | 54,114 (Direct) | View |
| 2023-05-02 Option Award | 2023-05-04 8:32 pm | 2025-05-02 2033-05-02 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 36,064 | $0 | 86,958 (Direct) | View |
| 2023-05-03 Tax Withholding | 2023-05-04 8:32 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 819 | $235.97 | 86,958 (Direct) | View |
| 2023-04-30 Tax Withholding | 2023-05-02 8:28 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 666 | $239.74 | 51,713 (Direct) | View |
| 2023-03-17 Tax Withholding | 2023-03-20 7:14 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 3,978 | $234.57 | 52,379 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:04 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 7,947 | $0 | 56,167 (Direct) | View |
| 2022-11-02 Tax Withholding | 2022-11-03 9:38 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,440 | $272.06 | 48,136 (Direct) | View |
| 2022-05-05 Tax Withholding | 2022-05-09 7:12 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 575 | $236.1 | 50,307 (Direct) | View |
| 2022-05-03 Tax Withholding | 2022-05-04 8:07 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 770 | $230.92 | 82,699 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 8:07 pm | 2024-05-02 2032-05-02 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 35,714 | $0 | 82,699 (Direct) | View |
| 2022-04-27 Tax Withholding | 2022-04-29 6:47 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 184 | $249.87 | 47,755 (Direct) | View |
| 2022-03-18 Tax Withholding | 2022-03-22 5:47 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 4,995 | $235.86 | 47,939 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:33 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 9,989 | $0 | 52,714 (Direct) | View |
| 2021-11-02 Tax Withholding | 2021-11-03 7:27 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,192 | $209.74 | 42,593 (Direct) | View |
| 2021-05-01 Tax Withholding | 2021-05-04 7:41 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,854 | $239.64 | 79,254 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 7:41 pm | 2023-04-30 2031-04-30 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 38,788 | $0 | 79,254 (Direct) | View |
| 2021-04-27 Tax Withholding | 2021-04-28 8:17 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 174 | $255.52 | 42,320 (Direct) | View |
| 2021-03-19 Tax Withholding | 2021-03-22 6:34 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,401 | $244.42 | 42,494 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 8:35 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,803 | $0 | 43,715 (Direct) | View |
| 2021-02-16 Tax Withholding | 2021-02-16 8:59 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,147 | $237.21 | 40,912 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-16 8:59 pm | 2013-04-25 2021-04-25 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,300 | $0 | 40,912 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-16 8:59 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,300 | $54.69 | 40,912 (Direct) | View |
| 2020-11-02 Tax Withholding | 2020-11-04 7:06 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 2,125 | $216.94 | 39,619 (Direct) | View |
| 2020-05-05 Option Award | 2020-05-07 9:04 pm | 2022-05-05 2030-05-05 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 32,519 | $0 | 70,458 (Direct) | View |
| 2020-05-01 Tax Withholding | 2020-05-05 7:57 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,046 | $239.22 | 37,939 (Direct) | View |
| 2020-05-03 Tax Withholding | 2020-05-05 7:57 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 185 | $230.98 | 37,939 (Direct) | View |
| 2020-04-27 Tax Withholding | 2020-04-29 7:04 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 168 | $236.28 | 39,170 (Direct) | View |
| 2020-03-20 Tax Withholding | 2020-03-24 6:09 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,855 | $198.76 | 39,338 (Direct) | View |
| 2020-03-09 Exercise | 2020-03-10 9:12 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,480 | $58.43 | 40,985 (Direct) | View |
| 2020-03-09 Exercise | 2020-03-10 9:12 pm | 2012-04-26 2020-04-26 | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 1,480 | $0 | 40,985 (Direct) | View |
| 2020-03-09 Tax Withholding | 2020-03-10 9:12 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 780 | $210.65 | 40,985 (Direct) | View |
| 2020-03-03 Option Award | 2020-03-05 7:58 pm | N/A N/A | AMGEN INC | AMGN | REESE DAVID M EVP, Research and Development | 3,711 | $0 | 40,285 (Direct) | View |